Application 209425

Type: ANDA
Sponsor: APOTEX

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	CARFILZOMIB	CARFILZOMIB	POWDER;INTRAVENOUS	60MG/VIAL	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A209425-001	CARFILZOMIB	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS			2020-03-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`c0c555d07b60…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A209425-001	CARFILZOMIB	60MG/VIAL	POWDER / INTRAVENOUS	2020-03-16	`a50c72e98297…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
KYPROLIS	CARFILZOMIB	Onyx Pharmaceuticals, Inc.	ea66eb30-e665-4693-99a1-a9d3b4bbe2d6	2025-06-18	Warnings, Adverse reactions	Name fallback generic name: CARFILZOMIB

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
Document	Submission type	Date
57750	ORIG	2019-02-21